Iqvia price target lowered to $220 from $235 at Wells Fargo

Wells Fargo analyst Timothy Daley lowered the firm’s price target on Iqvia to $220 from $235 and keeps an Equal Weight rating on the shares ahead of quarterly results. The firm believes its combined data, tech, and research assets will enable it to spur growth and expand its TAM, but that this gain is aptly captured in estimates and valuation.